 Mohammad Rahman
Concepts (129)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Splicing | 7 | 2023 | 43 | 2.400 |
Why?
| | Neoplasms | 4 | 2026 | 1334 | 1.560 |
Why?
| | RNA Splice Sites | 4 | 2022 | 10 | 1.270 |
Why?
| | Alternative Splicing | 8 | 2023 | 61 | 1.250 |
Why?
| | Nonsense Mediated mRNA Decay | 3 | 2023 | 6 | 1.080 |
Why?
| | Exons | 8 | 2022 | 100 | 1.030 |
Why?
| | RNA Precursors | 4 | 2023 | 9 | 0.960 |
Why?
| | Superoxide Dismutase | 1 | 2026 | 122 | 0.930 |
Why?
| | Antioxidants | 1 | 2026 | 264 | 0.830 |
Why?
| | Myasthenic Syndromes, Congenital | 4 | 2017 | 8 | 0.730 |
Why?
| | Mitochondria | 1 | 2026 | 446 | 0.720 |
Why?
| | Mutation | 6 | 2020 | 1337 | 0.710 |
Why?
| | Introns | 4 | 2023 | 51 | 0.640 |
Why?
| | RNA Stability | 1 | 2020 | 29 | 0.620 |
Why?
| | Myelodysplastic Syndromes | 1 | 2020 | 87 | 0.600 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group F-H | 2 | 2017 | 2 | 0.600 |
Why?
| | Acetylcholinesterase | 2 | 2017 | 21 | 0.590 |
Why?
| | Polypyrimidine Tract-Binding Protein | 2 | 2017 | 11 | 0.540 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein L | 2 | 2014 | 3 | 0.520 |
Why?
| | Muscle Proteins | 2 | 2017 | 350 | 0.480 |
Why?
| | Collagen | 1 | 2015 | 215 | 0.420 |
Why?
| | Gene Expression Regulation | 4 | 2017 | 1003 | 0.420 |
Why?
| | Receptors, Nicotinic | 1 | 2013 | 72 | 0.390 |
Why?
| | HeLa Cells | 5 | 2020 | 243 | 0.360 |
Why?
| | RNA, Messenger | 5 | 2023 | 1133 | 0.350 |
Why?
| | Protein Binding | 6 | 2019 | 670 | 0.310 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2020 | 208 | 0.270 |
Why?
| | Humans | 18 | 2026 | 53230 | 0.270 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2026 | 19 | 0.240 |
Why?
| | Sumoylation | 1 | 2026 | 21 | 0.240 |
Why?
| | Ubiquitination | 1 | 2026 | 58 | 0.230 |
Why?
| | Codon, Nonsense | 2 | 2023 | 27 | 0.230 |
Why?
| | Base Sequence | 5 | 2022 | 620 | 0.230 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2023 | 187 | 0.230 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2026 | 141 | 0.220 |
Why?
| | Oxidation-Reduction | 1 | 2026 | 333 | 0.220 |
Why?
| | Endothelial Cells | 1 | 2026 | 289 | 0.200 |
Why?
| | Animals | 8 | 2026 | 13526 | 0.200 |
Why?
| | K562 Cells | 2 | 2020 | 42 | 0.200 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2023 | 43 | 0.190 |
Why?
| | Disease Progression | 1 | 2026 | 880 | 0.190 |
Why?
| | Pancreatitis | 1 | 2023 | 69 | 0.190 |
Why?
| | Binding Sites | 4 | 2019 | 373 | 0.190 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2022 | 7 | 0.180 |
Why?
| | Cell Differentiation | 2 | 2023 | 681 | 0.180 |
Why?
| | Pancreatic Neoplasms | 1 | 2023 | 219 | 0.170 |
Why?
| | Spliceosomes | 1 | 2020 | 10 | 0.160 |
Why?
| | Cell Line | 4 | 2017 | 1016 | 0.160 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2019 | 1 | 0.150 |
Why?
| | RNA-Binding Proteins | 2 | 2018 | 133 | 0.150 |
Why?
| | Nucleotide Motifs | 2 | 2022 | 22 | 0.150 |
Why?
| | Computational Biology | 2 | 2022 | 209 | 0.150 |
Why?
| | Signal Transduction | 1 | 2026 | 1748 | 0.150 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 1470 | 0.150 |
Why?
| | RNA | 1 | 2019 | 173 | 0.140 |
Why?
| | Models, Molecular | 1 | 2019 | 352 | 0.140 |
Why?
| | Models, Biological | 3 | 2017 | 737 | 0.130 |
Why?
| | Cholinergic Agents | 1 | 2017 | 5 | 0.130 |
Why?
| | Gene Order | 2 | 2014 | 13 | 0.130 |
Why?
| | Neuromuscular Junction | 1 | 2017 | 9 | 0.130 |
Why?
| | HEK293 Cells | 3 | 2026 | 235 | 0.130 |
Why?
| | Polyadenylation | 1 | 2017 | 21 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2019 | 412 | 0.120 |
Why?
| | Genome, Human | 1 | 2016 | 121 | 0.120 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2014 | 1 | 0.110 |
Why?
| | Y-Box-Binding Protein 1 | 1 | 2014 | 1 | 0.110 |
Why?
| | Receptors, Cholinergic | 1 | 2014 | 14 | 0.110 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2014 | 52 | 0.110 |
Why?
| | Proline-Rich Protein Domains | 1 | 2013 | 1 | 0.100 |
Why?
| | Motor Endplate | 1 | 2013 | 3 | 0.100 |
Why?
| | Software | 1 | 2016 | 280 | 0.100 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2013 | 41 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 505 | 0.100 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 563 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 759 | 0.090 |
Why?
| | Cell Nucleus | 2 | 2026 | 187 | 0.090 |
Why?
| | Gene Expression | 3 | 2019 | 618 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2013 | 1212 | 0.080 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 815 | 0.070 |
Why?
| | Regulatory Elements, Transcriptional | 2 | 2017 | 8 | 0.070 |
Why?
| | Mice | 3 | 2026 | 5982 | 0.070 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2026 | 10 | 0.060 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2026 | 35 | 0.060 |
Why?
| | SUMO-1 Protein | 1 | 2026 | 15 | 0.060 |
Why?
| | Proteolysis | 1 | 2026 | 105 | 0.060 |
Why?
| | Organ Specificity | 2 | 2016 | 115 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2026 | 392 | 0.050 |
Why?
| | Position-Specific Scoring Matrices | 1 | 2022 | 1 | 0.050 |
Why?
| | Survival of Motor Neuron 2 Protein | 1 | 2022 | 2 | 0.050 |
Why?
| | Base Composition | 1 | 2022 | 24 | 0.050 |
Why?
| | Gene Library | 1 | 2022 | 40 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 96 | 0.040 |
Why?
| | RNA Polymerase II | 1 | 2019 | 15 | 0.040 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2019 | 21 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2019 | 21 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2019 | 46 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2019 | 38 | 0.040 |
Why?
| | Cross-Linking Reagents | 1 | 2019 | 43 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2019 | 119 | 0.040 |
Why?
| | Nucleic Acid Conformation | 1 | 2019 | 82 | 0.040 |
Why?
| | Inflammation | 1 | 2023 | 652 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2018 | 59 | 0.040 |
Why?
| | Middle Aged | 1 | 2013 | 13419 | 0.030 |
Why?
| | Male | 2 | 2019 | 27435 | 0.030 |
Why?
| | Models, Genetic | 1 | 2018 | 169 | 0.030 |
Why?
| | Cleavage Stimulation Factor | 1 | 2017 | 1 | 0.030 |
Why?
| | Caco-2 Cells | 1 | 2017 | 31 | 0.030 |
Why?
| | GPI-Linked Proteins | 1 | 2017 | 32 | 0.030 |
Why?
| | Binding, Competitive | 1 | 2017 | 89 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 423 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 109 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 367 | 0.030 |
Why?
| | Phosphorylation | 1 | 2018 | 533 | 0.030 |
Why?
| | Isoenzymes | 1 | 2017 | 165 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2016 | 10 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 180 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2019 | 1031 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2019 | 868 | 0.030 |
Why?
| | DNA Methylation | 1 | 2019 | 592 | 0.030 |
Why?
| | Silencer Elements, Transcriptional | 1 | 2014 | 1 | 0.030 |
Why?
| | Muscle Development | 1 | 2014 | 24 | 0.030 |
Why?
| | Transcription Factors | 1 | 2018 | 571 | 0.030 |
Why?
| | Genetic Loci | 1 | 2014 | 48 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2014 | 124 | 0.030 |
Why?
| | Wnt Proteins | 1 | 2014 | 104 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 867 | 0.030 |
Why?
| | Rats | 1 | 2017 | 3162 | 0.020 |
Why?
| | Adult | 1 | 2016 | 14534 | 0.010 |
Why?
| | Female | 1 | 2019 | 28782 | 0.010 |
Why?
|
|
Rahman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|